Balyasny Asset Management
MRK icon

Balyasny Asset Management’s Merck MRK Stock Holding History

Balyasny Asset Management’s Portfolio MRK Stock Details MRK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.95M Buy
16,200
+2,300
+17% +$266K ﹤0.01% 1792
2025
Q4 		$1.46M Sell
13,900
-43,700
-76% -$4.1M ﹤0.01% 2010
2025
Q3 		$4.83M Buy
57,600
+31,000
+117% +$2.55M 0.01% 1381
2025
Q2 		$2.11M Sell
26,600
-17,900
-40% -$1.42M ﹤0.01% 1704
2025
Q1 		$3.99M Buy
44,500
+19,200
+76% +$1.79M 0.01% 1357
2024
Q4 		$2.52M Buy
25,300
+2,900
+13% +$299K ﹤0.01% 1589
2024
Q3 		$2.54M Buy
22,400
+11,800
+111% +$1.4M ﹤0.01% 1576
2024
Q2 		$1.31M Buy
10,600
+2,100
+25% +$271K ﹤0.01% 1689
2024
Q1 		$1.12M Sell
8,500
-2,800
-25% -$345K ﹤0.01% 1739
2023
Q4 		$1.23M Buy
11,300
+4,100
+57% +$426K ﹤0.01% 1604
2023
Q3 		$741K Buy
+7,200
New +$776K ﹤0.01% 1643
2022
Q4 		– Sell
-109,600
Closed -$9.44M – 3056
2022
Q3 		$9.44M Buy
109,600
+55,600
+103% +$4.96M 0.03% 715
2022
Q2 		$4.92M Buy
+54,000
New +$4.79M 0.02% 942
2022
Q1 		– Sell
-10,000
Closed -$766K – 2701
2021
Q4 		$766K Sell
10,000
-710,000
-99% -$56.6M ﹤0.01% 1520
2021
Q3 		$54.1M Buy
720,000
+710,000
+7,100% +$54M 0.23% 94
2021
Q2 		$778K Sell
10,000
-998,176
-99% -$74.2M ﹤0.01% 1397
2021
Q1 		$74.2M Buy
1,008,176
+615,176
+157% +$45.4M 0.37% 44
2020
Q4 		$30.7M Buy
+393,000
New +$30.1M 0.17% 158
2018
Q4 		– Sell
-115,280
Closed -$7.7M – 1615
2018
Q3 		$7.7M Buy
+115,280
New +$7.34M 0.03% 567
2018
Q2 		– Sell
-288,200
Closed -$15M – 2017
2018
Q1 		$15M Buy
+288,200
New +$15.6M 0.06% 404
2016
Q3 		– Sell
-262,000
Closed -$14.4M – 1174
2016
Q2 		$14.4M Buy
+262,000
New +$13.9M 0.09% 281
2015
Q2 		– Sell
-628,800
Closed -$34.5M – 1257
2015
Q1 		$34.5M Buy
+628,800
New +$35.6M 0.28% 101

Other funds holding MRK

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Balyasny Asset Management's MRK Position: Q1 2026 in Review

Balyasny Asset Management reduced its Merck (MRK) stake by 17% in Q1 2026, selling an estimated $43.3M and leaving 1,812,608 shares worth $218M. The position accounts for 0.28% of the portfolio, ranked #53.

Balyasny Asset Management first reported a position in MRK in Q3 2013 and has held it in 43 quarters since. The position peaked at $230M in Q4 2025. 3,780 funds tracked by Wall St. Rank hold MRK as of Q1 2026.

  • Balyasny Asset Management held 1,812,608 shares of Merck worth $218M as of Q1 2026.
  • Balyasny Asset Management sold 374,652 Merck shares in Q1 2026, an estimated $43.3M.
  • Merck made up 0.28% of Balyasny Asset Management's portfolio in Q1 2026, its #53 holding.
  • Balyasny Asset Management first reported a position in Merck in Q3 2013 and has held it in 43 quarters since.
  • Balyasny Asset Management's Merck position peaked at $230M in Q4 2025.
  • 3,780 funds tracked by Wall St. Rank held Merck as of Q1 2026.

Based on Balyasny Asset Management's 13F filing for Q1 2026, filed 15 May 2026.